For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Joanna Wiśniewska-Kruk explores the role of plasmalemma vesicle-associated protein (PLVAP) in the development and progression of diabetic retinopathy (DR). Diabetic retinopathy is a multifactorial disease that can progress from minor changes in vascular permeability, into a vision-threatening proliferative retinal disorder. Elucidation of the functions of PLVAP in endothelium and its possible implication in the development of DR may help to develop new, more effective therapeutic approaches in the clinic.

Event details of Insight in development of diabetic retinopathy
Date 28 October 2014
Time 10:00 -11:00
Location Agnietenkapel

J. Wiśniewska-Kruk, PLVAP in Diabetic Retinopathy: A Gatekeeper of Angiogenesis and Vascular Permeability.

Supervisor

Prof. R.O. Schlingemann
Prof. C.J.F. van Noorden

Co-supervisor

Dr I. Klaassen

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.